Marex Group announces public offering of 8.5 million shares

NEW YORK - Marex Group plc (NASDAQ:MRX), a diversified global financial services platform with a market capitalization of $2.63 billion and strong financial health rating according to InvestingPro, today disclosed the launch of a public offering of 8.5 million ordinary shares by certain selling shareholders. Alongside the initial offering, these shareholders have given underwriters a 30-day option to purchase up to an additional 1.275 million shares. The stock, which trades at a P/E ratio of 12.7 and has delivered a 20.5% return year-to-date, has shown robust revenue growth of 25.2% over the last twelve months.

The offering is being managed by Goldman Sachs & Co. LLC, Barclays, and Jefferies, which are acting as the lead book-running managers. Marex Group has clarified that it will not be selling any shares itself and consequently will not receive any proceeds from this offering.

Interested parties can obtain copies of the preliminary prospectus from the managing firms. The offering is contingent upon a registration statement filed with the U.S. Securities and Exchange Commission, which at this time has not become effective. Therefore, the securities cannot be sold, nor offers to buy accepted, until the registration statement is effective.

This announcement does not constitute an offer to sell or a solicitation of an offer to buy any securities. The sale or the solicitation of an offer to buy these securities will not be lawful in any jurisdiction where such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction.

The information is based on a press release statement from Marex Group plc.

In other recent news, Marex Group has reported robust first-quarter results for 2025, with revenues reaching approximately $456.8 million, surpassing the consensus estimate of $428.2 million. The company’s diluted earnings per share (EPS) for the quarter were around $0.90, exceeding the forecast of $0.81. This strong performance has been attributed to high activity levels in Marex’s Prime Services and Energy businesses. Following these results, Keefe, Bruyette & Woods raised its price target for Marex to $45, maintaining an Outperform rating. Similarly, UBS increased its price target to $45, reiterating a Buy rating due to the company’s competitive stance and potential for earnings expansion. Jefferies also adjusted Marex’s price target to $42, citing increased client activity and favorable market conditions as key factors. Despite the broader market’s uncertainty, analysts from these firms express confidence in Marex’s strategic positioning and financial prospects. Marex’s recent acquisition activities, including Aarna Capital and Hamilton Court, are expected to contribute positively to its growth trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.